Merkel cell carcinoma: Analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival

被引:165
作者
Skelton, HG
Smith, KJ
Hitchcock, CL
McCarthy, WF
Lupton, GP
Graham, JH
机构
[1] LAB CORP AMER, HERNDON, VA 20306 USA
[2] ARMED FORCES INST PATHOL, DEPT DERMATOPATHOL, WASHINGTON, DC 20306 USA
[3] ARMED FORCES INST PATHOL, DEPT CELLULAR PATHOL, WASHINGTON, DC USA
[4] NATL NAVAL MED CTR, DEPT DERMATOL, BETHESDA, MD 20814 USA
[5] UNIFORMED SERV UNIV HLTH SCI, DEPT SURG, BETHESDA, MD USA
关键词
D O I
10.1016/S0190-9622(97)70110-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Merkel cell carcinoma (MCC) is an uncommon malignancy of the skin and has a high rate of recurrence and metastasis. There have been few large studies of the biologic behavior of MCC. Objective: Our purpose was to determine whether there were clinical or histologic features of MCC that predict its biologic behavior. Methods: We reviewed 132 cases of MCC. Clinical and histologic features were correlated with follow-up information to determine whether any of these were associated with prognosis. Results: Clinical information was available on 126 patients; 57 were alive, 1 was alive with tumor, 28 died of tumor, 27 died from other causes, and 14 were lost to follow-up. MCC on the buttock/thigh area or trunk had the worst prognosis, and these on the distal extremities had the best prognosis; however, the difference was not statistically significant. Sex and age were not significant factors. Small cell size, high mitotic rate, and large tumor size were associated with a low survival rate. When cell size was excluded, male sex and depth of invasion were associated with a worse survival, although these were not statistically significant. Conclusion: Cell size, mitotic rate, and tumor size are significant factors in relation to the biologic behavior of MCC.
引用
收藏
页码:734 / 739
页数:6
相关论文
共 26 条
[1]   MITOSIS COUNTING IN TUMORS [J].
BAAK, JPA .
HUMAN PATHOLOGY, 1990, 21 (07) :683-685
[2]   MERKEL CELL TUMOR OF THE SKIN - AN IMMUNOHISTOCHEMICAL STUDY [J].
DRIJKONINGEN, M ;
DEWOLFPEETERS, C ;
VANLIMBERGEN, E ;
DESMET, V .
HUMAN PATHOLOGY, 1986, 17 (03) :301-307
[3]  
GOULD E, 1985, AM J SURG PATHOL, V9, P109
[4]  
GOULD VE, 1985, LAB INVEST, V52, P334
[5]   PRIMARY CUTANEOUS NEUROENDOCRINE CARCINOMA (MERKEL CELL TUMOR) - AN ADNEXAL EPITHELIAL NEOPLASM [J].
HEENAN, PJ ;
COLE, JM ;
SPAGNOLO, DV .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (01) :7-16
[6]   NEURO-ENDOCRINE (MERKEL CELL) CARCINOMA OF THE SKIN - ITS NATURAL-HISTORY, DIAGNOSIS, AND TREATMENT [J].
HITCHCOCK, CL ;
BLAND, KI ;
LANEY, RG ;
FRANZINI, D ;
HARRIS, B ;
COPELAND, EM .
ANNALS OF SURGERY, 1988, 207 (02) :201-207
[7]  
KROLL MH, 1982, ARCH PATHOL LAB MED, V106, P404
[8]   BER-EP4 - NEW MONOCLONAL-ANTIBODY WHICH DISTINGUISHES EPITHELIA FROM MESOTHELIA [J].
LATZA, U ;
NIEDOBITEK, G ;
SCHWARTING, R ;
NEKARDA, H ;
STEIN, H .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (03) :213-219
[9]   MERKEL CELL-CARCINOMA - THE CLINICAL COURSE [J].
MERCER, D ;
BRANDER, P ;
LIDDELL, K .
ANNALS OF PLASTIC SURGERY, 1990, 25 (02) :136-141
[10]   NEUROENDOCRINE CARCINOMA OF THE SKIN (MERKEL CELL-CARCINOMA) - AN IMMUNOELECTRONMICROSCOPIC CASE-STUDY [J].
MOUNT, SL ;
TAATJES, DJ .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (01) :60-65